Doug: < OSIP > A stock from your List you posted Sunday. The Crunching Numbers, Insider Trades, and stuff...
Insider Trades:
OSIP
WE CAN'T FIND A REPORT TO MATCH YOUR REQUEST.
INSIDER TRANSACTIONS OF FEWER
THAN 100 SHARES ARE NOT INCLUDED.
ENTER A STOCK SYMBOL, OR TYPE /C
TO SEARCH FOR A REPORT BY COMPANY NAME.
*** I guess this means there are no insiders buying or Selling.***
EPS 2/14/98 Page 1 of 1
OSI PHARMACEUTICALS INC.
Fiscal year ends 9/98
Earnings per share estimates
--Mean $ -0.45
--High $ -0.45
--Low $ -0.45
P/E Ratio -14.17 (Estimated)
Number of analysts 2
Past EPS estimates (Mean)
-- Month ago -0.46
--13 Weeks ago -0.46
--26 Weeks ago -0.49
***************
** Looks like company picked up a new analysts. An Extra Buy Rating this month ***
EPS 2/14/98 Page 1 of 3
OSI PHARMACEUTICALS INC.
Analyst's ratings 2/14/98 Month ago
Strong buy 1 1
Buy 2 1
Neutral 0 0
Sell 0 0
Strong sell 0 0
Total analysts 3 2
following company
**********************
PROFESSIONAL INVESTOR REPORT
02/20 DOW JONES PIR PROFILE OSI Pharm (Q: OSIP)
ESTIMATES UPDATED 2/12
Biopharm co. Uses Close 6 9/16 Consensus Rec. BUY
proprietary tech to R&D 52-Week High 11 7/8 3 Analysts 1.7
treatments for cancer, 52-Week Low 4 1/4 1Q EPS Est None
cardiovascular, other Dividend Yield None
diseases releated to cell Industry Avg 1.36% 4Q Oper EPS (0.15)
growth abnormalities. 8/97 1998 EPS Est (0.45)
with Pfizer's (PFE), co 3 Analysts
began phase I trials for Beta vs DJEI 2.44 1997 Oper EPS (0.44)
CP-358,774 for cancer. 5-Yr EPS Growth n.a.
Formerly Oncogene Sci. 1Q Rev $4.19M +80.9% Industry Avg 17.8%
TTM $16.65M +70.6% P/E Ratio ...
1Q Ern ($2.47M) ... Industry Avg 28.85
TTM ($9.36M) ... Projected P/E None
HQ Uniondale, NY 1-Yr Tot Rtrn (12.49%)
IR Phone 516-222-0023 Industry Avg 51.97%
(Updated 2/19 Sources: First Call, Market Guide For Help, use N/HLP)
(END) Dow Jones Newswires 02-20-98
08:39 PM EST
*********************************************************8
Financial Profile
Data current through 02/20/1998
Osi Pharmaceuticals Inc
106 Charles Lindbergh Blvd
Uniondale, NY 11553-3649
Telephone: (516) 222-0023
Fax: (516) 222-0114
Dow Jones Industry Group: Biotechnology
Business Description: Drug discovery company applying
proprietary, broadly enabling technologies to rapidly and
cost-effectively discover and develop novel small molecule
compounds for the treatment of major human diseases.
Primary SIC: 2835
SIC Codes: 8099 8731
Stock Symbol: OSIP
Exchange: NASDAQ
CEO: Gary E. Frashier
Employees: 156
Auditors: KPMG Peat Marwick LLP
Latest Report: Unqualified
Share Data
Latest Reported Shares Outstanding 21,367,000
Latest Shares Outstanding Date 02/17/1998
Latest Balance Sheet Shares Outstanding 21,367,000
Short Interest Shares 53,410
Short Interest Ratio 0.8 Days
Short Interest Ratio Date 01/08/1998
Net Insider Transactions 0
Net Insider Transactions Date 12/31/1997
Shares Held by Institutions 6,809,000
Number of Institutions Holding 52
% of Shares Held by Institutions 30.7
Institutional Holding Date 01/31/1998
Market Value($ Mil) 147
Market Value as % Revenues 993
Dividend Information
Last Ex-Dividend Date NA
Indicated Dividend Rate 0.00
Dividend Yield 0.0%
Dividend Code
Payout Ratio Last Fiscal Year NC
5-Year Average Payout NC
5-Year Dividend Yield 0.0%
Stock Price ($) And Volume
Most Recent Close Price 6.88
Most Recent Close Price Date 02/20/1998
Close Price 4 Weeks Ago 7.50
Close Price 13 Weeks Ago 7.38
Close Price 26 Weeks Ago 8.75
Close Price 52 Weeks Ago 7.13
Price Change Last Month 9.0%
Price Change Last 10 Days 11.1%
Price Change Last 26 Weeks -21.4%
Price Change Last 52 Weeks -3.5%
Price Change YTD 1.9%
Price Change vs Market Last Trading Week 106%
Price Change vs Market Last 4 Weeks 85%
Price Change vs Market Last 13 Weeks 87%
Price Change vs Market Last 26 Weeks 70%
Price Change vs Market Last 52 Weeks 75%
Price Change vs Market YTD 96%
4-Week High Price 7.44
4-Week Low Price 5.75
13-Week High Price 8.31
13-Week Low Price 5.75
26-Week High Price 11.88
26-Week Low Price 5.75
52-Week High Price 11.88
52-Week Low Price 4.25
YTD High Price 8.31
YTD Low Price 5.75
5-Day Moving Avg Price 6.59
10-Day Moving Avg Price 6.40
10-Week Moving Avg Price 6.83
30-Week Moving Avg Price 8.40
200-Day Moving Avg Price 7.82
Beta, Up Market 3.91
Beta, Down Market 4.46
Shares Traded This Week 157,100
Volume as % of Shares Outstanding 0.74%
Avg Daily Volume Last 2 Weeks 112,200
Avg Daily Volume Last 4 Weeks 122,000
Avg Daily Volume Last 13 Weeks 95,500
Avg Daily Volume Last 26 Weeks 116,600
Avg Daily Volume Last 52 Weeks 103,000
Avg Daily Volume YTD 97,300
On-Balance Volume Index Last 4 Weeks 198%
Liquidity Ratio 15,830
P/E Ratio NE
5-Year High P/E NC
5-Year Low P/E NC
Selected Balance Sheet Items ($ Mil)
Fiscal Year End 09/30/1997 09/30/1996 09/30/1995 09/30/1994
Cash & Equivalent 8.6 13.4 17.9 0.3
Receivables 1.9 2.8 1.3 20.9
Inventories 0.0 0.0 0.0 1.7
Current Assets 34.5 51.0 29.1 24.2
Gr Fixed Assets 18.2 15.4 12.6 12.4
Accum Depr & Depl 10.4 8.9 6.9 5.8
Net Fixed Assets 7.8 6.5 5.7 6.6
Total Assets 59.6 73.5 44.1 42.0
Accounts Payable 4.2 3.7 2.8 2.5
Short-Term Debt 0.7 0.0 0.0 0.0
Curr Liabilities 4.9 3.8 3.0 3.0
Long-Term Debt 0.2 0.1 0.2 0.2
Total Liabilities 6.7 5.2 3.6 3.4
Preferred Equity 0.0 0.0 0.0 0.0
Common Equity 52.9 68.3 40.5 38.7
Retained Earnings -45.7 -36.1 -26.1 -21.9
Total Equity 52.9 68.3 40.5 38.7
Liabs & Equity 59.6 73.5 44.1 42.1
Working Capital 29.6 47.2 26.1 21.2
Selected Income Statement Items ($ Mil)
Fiscal Year End 09/30/1997 09/30/1996 09/30/1995 09/30/1994
Revenues/Sales 14.8 9.7 15.9 16.3
Cost of Sales -2.0 -2.1 0.2 0.3
Gr Oper Profit 16.8 11.8 15.7 16.0
S,G & A Expenses 24.3 20.2 20.7 19.6
Deprec & Amort 4.1 3.7 2.7 2.9
Interest Expense 0.0 0.0 0.0 0.0
Pretax Income -9.6 -9.9 -4.3 -5.7
Income Taxes 0.0 0.0 0.0 0.0
Minority Interest 0.0 0.0 0.0 0.0
Net Inc Cont Ops -9.6 -9.9 -4.3 -5.7
Net Inc Disc Ops 0.0 0.0 0.0 0.0
Net Inc Tot Ops -9.6 -9.9 -4.3 -5.7
Extra Inc (Loss) 0.0 0.0 0.0 0.0
Net Income -9.6 -9.9 -4.3 -5.7
EPS Cont Ops -0.44 -0.50 -0.25 -0.35
EPS Disc Ops 0.00 0.00 0.00 0.00
EPS Total Ops -0.44 -0.50 -0.25 -0.35
EPS Extra Inc 0.00 0.00 0.00 0.00
EPS fr Net Income -0.44 -0.50 -0.25 -0.35
Domestic Sales NA NA NA NA
Foreign Sales NA NA NA NA
Income Statement YTD (last annual value if no qtrly aval for cur yr)
Revenues/Sales($ Mil) 14.8
Inc fr Total Ops($ Mil) -9.6
EPS fr Total Ops($) -0.44
Dividends per Share($) 0.00
Selected Cash Flow Statement Items ($ Mil)
Fiscal Year End 09/30/1997 09/30/1996 09/30/1995 09/30/1994
Net Income -9.6 -9.9 -4.3 -5.7
Deprec & Amort 4.1 3.7 2.7 2.9
Chg Receivables 1.0 -0.7 1.9 0.2
Chg Payables 0.5 0.4 -0.6 0.2
Net Cash fr Ops -3.4 -6.1 -3.0 -2.2
Net Cash fr Inv 7.0 -30.4 15.1 1.6
Net Cash fr Fin -8.3 32.0 5.5 0.0
Eff Exch Rate Chg 0.0 0.0 0.0 0.0
Net Chg Cash & Eq -4.8 -4.5 17.6 -0.5
Cash Begin Period 13.4 17.9 0.3 0.8
Key Financial Ratios
Fiscal Year End 09/30/1997 09/30/1996 09/30/1995 09/30/1994
Book Value P/S 2.48 3.11 2.32 2.37
Price/Book Val(%) 439 285 232 137
Debt/Equity(%) 0 0 0 1
LT Debt % Inv Cap 0.4 0.1 0.5 0.5
LT Debt % Tot Dbt 3.0 1.9 5.6 5.9
Dbt % Tot Assets 11.2 7.1 8.2 8.1
Quick Ratio 2.1 4.3 6.4 7.1
Current Ratio 7.0 13.4 9.7 8.1
Revenue/Assets(%) 20 10 40 40
Price/Revenue(%) 1,576 2,017 591 325
Cash % Revenue 58.1 138.1 112.6 1.8
Pre-Tax Mgn(%) -64.9 NC -27.0 -35.0
Post-Tax Mgn(%) -64.9 NC -27.0 -35.0
Eff Tax Rate(%) 0.0 0.0 0.0 0.0
Asset Turnover 0.2 0.2 0.4 0.4
Receivable Turn 6.3 4.7 1.4 0.7
Inventory Turn NC NC 0.2 0.2
Ret on Equity(%) NE NE NE NE
Ret Invest Cap(%) -18.1 -14.5 -10.6 -14.7
Ret on Assets(%) -16.1 -13.5 -9.8 -13.6
Growth Rates
5-Yr Annual EPS Growth NC
5-Yr Annual Div Growth NC
5-Yr Annual Revenue Growth -1.15%
% Change EPS YTD vs Last YTD NE
$ Change in EPS this YTD vs Last YTD 0.00 |
